Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,653,561
+$482,992 QoQ
Shares Held
14,519
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#1,516
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aull & Monroe Investment Management Corp holds $30,785,948 across 9 Drug Manufacturers - General names. ABBV ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,329 | $11,189,483 | |
| 2 | JNJ |
Johnson & Johnson
|
30,562 | $7,761,831 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,519 | $3,653,561 | |
| 4 | AMGN |
Amgen Inc
|
9,494 | $3,437,967 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,386 | $2,362,601 | |
| 6 | PFE |
Pfizer Inc
|
38,318 | $922,697 | |
| 7 | NVS |
Novartis AG
|
3,771 | $590,991 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,214 | $530,910 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,653,561 | 14,519 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,170,569 | 14,578 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,341,894 | 14,626 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $3,387,893 | 14,632 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,792,652 | 15,045 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,874,024 | 18,490 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,285,673 | 18,490 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,874,557 | 19,620 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,370,882 | 19,653 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $3,994,363 | 21,935 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,466,678 | 22,370 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $3,389,624 | 22,740 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,090,706 | 22,940 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $3,655,947 | 22,940 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,693,758 | 22,856 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,149,908 | 23,470 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,594,665 | 23,470 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,804,721 | 23,470 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,181,223 | 23,495 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,557,489 | 23,709 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,664,949 | 23,659 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,560,376 | 23,659 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,481,915 | 23,163 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,039,445 | 23,284 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,148,571 | 21,884 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,814,007 | 23,809 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||